Phase I trial of recombinant interferon gamma in cancer patients.
Saroj Vadhan‐Raj(The University of Texas MD Anderson Cancer Center), Susan E. Krown(Memorial Sloan Kettering Cancer Center), Rajiv Bhalla(Memorial Sloan Kettering Cancer Center), Herbert F. Oettgen, Ayad Al‐Katib(Wayne State University), Louis M. Pelus(Maryland Oncology Hematology), Stephen A. Sherwin(University of California, San Francisco), Carl Nathan(Cornell University)
Cited by 122
Related Papers
Secretory products of macrophages.
|Journal of Clinical Investigation|1987|2.6k
Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
|Journal of Clinical Oncology|2011|1.3k
Kaposi sarcoma
|Nature Reviews Disease Primers|2019|707
Suppression of arthritis by an inhibitor of nitric oxide synthase.
|The Journal of Experimental Medicine|1993|652